Business and healthcare professionals gathered at Mintz Levin on Thursday, April 17 to celebrate the winners of the Massachusetts Medical Device Development (M2D2) Center’s New Venture Competition. 15 companies hoped to launch ideas ranging from microarrays for spinal pain to transdermal drug delivery devices, aided by the nearly $100,000 in funding and services offered by M2D2 and their partners.
PixelEXX Systems, a company hoping to launch a line of cameras using semiconductor technology to shrink pixel sizes, clinched first place. “In 2016, we hope to be manufacturing these cameras for medical endoscopy, but also for areas beyond medical imaging,” said Renee Carder, PhD, VP of Technology at PixelEXX. The company has raised $2.8 million in private funding so far; this award from M2D2 adds $35,000 in funds and in-kind services to the pot.
Three companies tied for second place: Micro-Leads, lead by Bryan McLaughlin, MD, PhD, hopes to innovate in the area of chronic back pain through the use of transformative spinal-cord stimulation through electrode arrays that can focus stimulation delivery with fewer cords. In addition to his engineering and medical training, McLaughlin is a patient who has dealt with chronic back pain himself. He won $10,000 to grow his technology and begin pilot projects.
Wellumina, a team hoping to provide at home urinalysis tests with clinical-grade accuracy, also clinched a second place win and $10,000. As urinalysis tests are the second most commonly used test in America, the team proposes hopes to introduce disposable kits that link to apps, which can produce quantitative results and send these results to physicians. “This is of broad relevance for a wide variety of conditions,” Niraj Agarwal, CTO, said during his presentation.
Team Novopyxis also placed second in the competition, winning $10,000. The company is working on a solution for the transdermal delivery of antibiotics for skin and soft tissue infections. Their concept is needle-free and contact-free, and also fairly inexpensive.
Gel4Med placed third, winning $9,000; Soft Robotics placed fourth, securing $8,000 in funding; Nido Surgical placed fifth, taking home a $7,000 award. Resorbium and Admetsys walked away with honorable mentions.
Jenni Whalen is the Executive Assistant of Editorial at Upworthy. She was previously MedTech Boston's Managing Editor and has an MS in Journalism from Boston University, as well as a BA in Psychology from Bucknell University. Whalen has written for Greatist, Boston magazine, AZ Central Healthy Living and the New England Journal of Medicine, among other places. She has also worked as a conference planner, ghost writer, researcher and content developer.
Send this to friend